Is SLF a Buy or a Sell? The Bull and Bear Case (2026)

The most concrete risk sits in U.S. dental. DentaQuest cost roughly US$2.5 billion in 2022 and the business has since absorbed Medicaid redetermination-driven membership loss, a C$61 million (US$45 million) intangible impairment in the second quarter of 2025 from the early termination of a group dental contract, and repricing that management describes as in progress rather than finished. U.S. underlying net income was flat between 2024 and 2025 at roughly C$770 million while the rest of the group grew, and the second quarter of 2026 showed lower Medicaid dental sales even as stop-loss boomed. Any federal or state tightening of Medicaid dental benefits reaches revenue directly. Second, MFS is losing assets. Net outflows were US$22.9 billion in the second quarter of 2026 alone (US$13.7 billion retail, US$9.2 billion institutional) and C$58.1 billion across 2025; the segment's earnings have held up on higher average net assets and a 35.7% pre-tax operating margin, so a market drawdown would hit fee income and flows at the same time. Third, the balance sheet has levered up. The financial leverage ratio rose to 23.8% from 20.1% at the end of 2024, subordinated debt reached C$8,920 million, and the SLF Inc. LICAT ratio fell to 145% from 157% at the end of 2025 as the affiliate buy-ups and Bell Partners were funded. Fourth, reported earnings remain hostage to marks: interest rate impacts cost C$179 million after tax in the first half of 2026 and investment property revaluations another C$86 million. Finally, for a U.S. holder the entire earnings stream is Canadian dollar denominated, so a weaker loonie cuts the dividend and the quote regardless of how the business performs.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding SLF already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Too few analysts publish on SLF for a consensus target to mean anything, so there is no professional average to weigh against your own view. That cuts both ways: less informed opinion to lean on, and less of it already priced in. The SLF forecast page covers what coverage does exist.

• Revenue (TTM): Sun Life reports in Canadian dollars. Total revenue on the company's own definition (insurance revenue plus net investment income plus fee income) was ~C$44.1 billion for the twelve months to June 30, 2026 (~US$32 billion at the ~1.38 average rate), versus C$41,900 million in 2025, C$38,633 million in 2024 and C$40,774 million in 2023. Data vendors quote a lower trailing figure near C$35.5 billion on a narrower revenue definition, which is where a screener's ~$35.5B line comes from. The line swings hard quarter to quarter (C$7,509 million to C$15,333 million over the past eight quarters) because net investment income moves with fair value changes on invested assets, so it is a poor gauge of the business under IFRS 17.
• Earnings and EPS: Reported net income to common shareholders was C$1,008 million in the second quarter of 2026, up 41%, and C$1,473 million for the first half, down from C$1,644 million a year earlier. Underlying net income was C$1,123 million in the quarter (up 11%) and C$2,173 million year to date. Reported diluted EPS was C$1.81 for the quarter and C$5.91 on a trailing twelve-month basis; underlying diluted EPS was C$2.02 and roughly C$7.73 trailing. Full-year 2025 underlying net income was C$4,201 million on underlying EPS of C$7.45, against reported C$3,472 million and C$6.15. The first-half gap comes from two first-quarter charges: C$165 million post-tax on the SLC affiliate buy-ups and C$145 million post-tax on a Canadian legal settlement.
• Segment mix and operating metrics: Second-quarter 2026 underlying net income split C$427 million Canada (up 23%), C$364 million Sun Life Asset Management, C$227 million U.S. (US$164 million, up 15%), C$222 million Asia (up 18%) and a C$117 million corporate loss. Full-year 2025 ran C$1,594 million Canada, C$1,371 million asset management, C$836 million Asia, C$770 million U.S. and a C$370 million corporate loss. Group AUM reached C$1,696 billion, up 10%. Within asset management, MFS held US$644.7 billion, SLC Management US$193.6 billion and Solutions and Other US$79.4 billion; total net inflows of US$1.5 billion masked US$22.9 billion of MFS outflows offset by a large ABSLAMC fixed income mandate. Group insurance sales rose 27% and individual insurance sales 16%.
• Balance sheet, capital and cash flow: Total assets were C$425.3 billion at June 30, 2026 against C$398.5 billion at the end of 2025, with total equity of C$26.8 billion and book value per common share of C$42.49 (C$40.25 at year-end 2025). Goodwill stood at C$9,732 million and subordinated debt at C$8,920 million, with a further C$200 million of innovative capital instruments. The contractual service margin, the stored future profit on in-force insurance contracts, was C$11.9 billion net of tax. The SLF Inc. LICAT ratio was 145% (Sun Life Assurance 133%), down from 157% at the end of 2025, and the financial leverage ratio was 23.8%. Cash and other liquid assets held at SLF Inc. and its wholly owned holding companies totalled C$2,292 million.
• Market pricing: SLF closed at ~US$78.98 on August 21, 2026, inside a 52-week range of US$57.22 to US$84.38, giving a market capitalization of ~US$44.0 billion (~C$60 billion) on ~554 million closing common shares. The headline P/E of ~18.9x is calculated on trailing reported IFRS EPS of C$5.91; on the underlying EPS of ~C$7.73 that management guides to, the multiple is closer to ~14x, and the forward P/E sits near ~13.1x. Price to book is roughly 2.6x against C$42.49 of book value per share. The dividend is C$0.96 a quarter (about US$0.696 as paid in September 2026), a yield of ~3.4% to ~3.5%, with ten consecutive years of increases.

Two multiples exist for the same stock and they differ by about five turns. The ~18.9x on reported EPS reflects IFRS 17 accounting that runs interest rate moves, investment property revaluations and deal charges straight through income; the ~14x on underlying EPS reflects what management and the sell side actually model. Neither is wrong, but comparing the reported figure against a U.S. peer that does not carry the same fair-value volatility will mislead. A 19.1% underlying ROE against a 2.6x book multiple is the trade the market is making.

Rather than asking whether SLF is a buy in the abstract, it tends to help to answer four questions:

• Thesis: do you believe the bull case above, and is it still true today?
• Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
• Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
• Overlap: check whether you already hold SLF indirectly through an index or sector ETF before adding more.

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

• Bull case breaks if: Asia is now the growth engine, led by Hong Kong stalls in the reported numbers rather than in the narrative around them.
• Bear case breaks if: the most concrete risk sits in U.S fails to materialise over several reporting periods while the drivers keep compounding.
• Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the SLF stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about SLF against your real portfolio and see your actual exposure before deciding.